Distinguished in Low Blood Sugar

Sandro G. Gentile

Via XXV Luglio, 160, 
Cava De Tirreni, IT 
Distinguished in Low Blood Sugar
Via XXV Luglio, 160, 
Cava De Tirreni, IT 
OverviewLocationsClinical Research

Overview

Sandro Gentile practices in Cava De Tirreni, Italy. Mr. Gentile is rated as a Distinguished expert by MediFind in the treatment of Low Blood Sugar. His top areas of expertise are Low Blood Sugar, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D).

His clinical research consists of co-authoring 332 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 22 articles in the study of Low Blood Sugar.

Gender
Male

Locations

Via XXV Luglio, 160, Cava De Tirreni, 84013, Italy
Other Locations
Via XXV Luglio, 160 Cava De Tirreni, Salerno, Italy
Torre Del Greco, 80059, Italy
Naples, Italy
Rome, Italy
Caserta, Italy
F.T. Camplani Clinica Ancelle Carità, Cremona, Italy
San Benedetto Del Tronto, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

Effects of the Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry
Effects of the Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular Geometry
Enrollment Status: Completed
Publish Date: May 25, 2021
Intervention Type: Drug
Study Phase: Phase 3

332 Total Publications

GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study.
GLP-1 Receptor Agonists Are Associated with Reduced Ascending Aorta Dilatation in Patients with Type 2 Diabetes: A Prospective Study.
Journal: International journal of molecular sciences
Published: September 15, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Gentile's expertise for a condition
ConditionClose
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile